MLZ Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Medipharm Labs Corp

Watchlist Manager

Watchlist

Price: 0.043 EUR 1.18%

Market Cap: €17.4m

M	Medipharm Labs Corp F:MLZ	CA
	Elanco Animal Health Inc NYSE:ELAN	US
S	Salesforce Inc XETRA:FOO	US
	Breville Group Ltd F:HDE	AU
S	Schweizer Electronic AG DUS:SCE	DE
	Gimv NV F:GI3	BE

Profitability Summary

Medipharm Labs Corp's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Healthy Gross Margin

27%

Sustainable 3Y Average Gross Margin

21%

Gross Margin is Increasing

-1% > 27%

Negative Operating Margin

-23%

Negative 3Y Average Operating Margin

-42%

Operating Margin is Increasing

-86% > -23%

Negative Net Margin

-18%

Negative 3Y Average Net Margin

-33%

Net Margin is Increasing

-68% > -18%

Negative Free Cash Flow Margin

-13%

Negative 3Y Average Free Cash Flow Margin

-24%

Free Cash Flow Margin is Increasing

-51% > -13%

Negative ROE

-21%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-35%

ROIC is Increasing

-45% > -30%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Healthy Gross Margin

27%

Sustainable 3Y Average Gross Margin

21%

Gross Margin is Increasing

-1% > 27%

Negative Operating Margin

-23%

Negative 3Y Average Operating Margin

-42%

Operating Margin is Increasing

-86% > -23%